B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 8.767 NOK -5.16% Market Closed
Market Cap: 342.7m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Wall Street
Price Targets

BGBIO Price Targets Summary
Bergenbio ASA

Wall Street analysts forecast BGBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BGBIO is 20.4 NOK with a low forecast of 5.05 NOK and a high forecast of 39.9 NOK.

Lowest
Price Target
5.05 NOK
42% Downside
Average
Price Target
20.4 NOK
133% Upside
Highest
Price Target
39.9 NOK
355% Upside
Bergenbio ASA Competitors:
Price Targets
SWTX
SpringWorks Therapeutics Inc
70% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
64% Upside
ACAD
ACADIA Pharmaceuticals Inc
45% Upside
4599
StemRIM Inc
135% Upside
RCEL
AVITA Medical Inc
94% Upside
TVTX
Travere Therapeutics Inc
48% Upside
MNPR
Monopar Therapeutics Inc
14% Upside
2696
Shanghai Henlius Biotech Inc
3% Downside

Revenue
Forecast

Revenue Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Bergenbio ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BGBIO's stock price target?
Price Target
20.4 NOK

According to Wall Street analysts, the average 1-year price target for BGBIO is 20.4 NOK with a low forecast of 5.05 NOK and a high forecast of 39.9 NOK.

Back to Top